DUSA Pharmaceuticals (DUSA)
DUSA Pharmaceuticals Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 5.37 | 5.44 | 5.30 | 5.44 | 60990 |
| May 24, 2012 | 5.22 | 5.40 | 5.15 | 5.40 | 61388 |
| May 23, 2012 | 5.30 | 5.30 | 5.10 | 5.23 | 82016 |
| May 22, 2012 | 5.28 | 5.45 | 5.28 | 5.35 | 94102 |
| May 21, 2012 | 5.16 | 5.27 | 5.140 | 5.27 | 77646 |
| May 18, 2012 | 5.05 | 5.20 | 4.96 | 5.17 | 199213 |
| May 17, 2012 | 5.00 | 5.199 | 4.95 | 5.12 | 196395 |
| May 16, 2012 | 5.29 | 5.36 | 4.99 | 5.01 | 159127 |
| May 15, 2012 | 5.36 | 5.48 | 5.26 | 5.29 | 116248 |
| May 14, 2012 | 5.51 | 5.51 | 5.35 | 5.37 | 173954 |
| May 11, 2012 | 5.90 | 5.90 | 5.51 | 5.56 | 178155 |
| May 10, 2012 | 6.17 | 6.18 | 5.75 | 5.80 | 141961 |
| May 9, 2012 | 6.33 | 6.33 | 6.11 | 6.13 | 64655 |
| May 8, 2012 | 6.27 | 6.44 | 5.80 | 6.40 | 540085 |
| May 7, 2012 | 6.11 | 6.43 | 6.02 | 6.29 | 163754 |
| May 4, 2012 | 6.18 | 6.24 | 6.01 | 6.10 | 146852 |
| May 3, 2012 | 6.08 | 6.62 | 6.07 | 6.19 | 388090 |
| May 2, 2012 | 5.81 | 6.16 | 5.76 | 6.06 | 141960 |
| May 1, 2012 | 5.89 | 5.96 | 5.71 | 5.82 | 148012 |
| April 30, 2012 | 5.93 | 5.99 | 5.85 | 5.86 | 84652 |
| April 27, 2012 | 5.89 | 6.00 | 5.80 | 5.92 | 107314 |
| April 26, 2012 | 5.76 | 5.86 | 5.70 | 5.86 | 93642 |
| April 25, 2012 | 5.79 | 5.84 | 5.69 | 5.78 | 89041 |
| April 24, 2012 | 5.68 | 5.74 | 5.63 | 5.71 | 68545 |
| April 23, 2012 | 5.81 | 5.81 | 5.47 | 5.69 | 167706 |
| April 20, 2012 | 5.64 | 5.90 | 5.580 | 5.89 | 152763 |
| April 19, 2012 | 5.64 | 5.749 | 5.54 | 5.55 | 74720 |
| April 18, 2012 | 5.85 | 5.85 | 5.58 | 5.61 | 124650 |
| April 17, 2012 | 5.80 | 5.90 | 5.77 | 5.85 | 110922 |
| April 16, 2012 | 5.60 | 5.75 | 5.53 | 5.73 | 69890 |
| April 13, 2012 | 5.75 | 5.76 | 5.59 | 5.59 | 68923 |
| April 12, 2012 | 5.69 | 5.80 | 5.69 | 5.74 | 73736 |
| April 11, 2012 | 5.57 | 5.80 | 5.50 | 5.67 | 191550 |
| April 10, 2012 | 5.99 | 5.99 | 5.45 | 5.50 | 241122 |
| April 9, 2012 | 5.88 | 5.88 | 5.63 | 5.81 | 229692 |
| April 5, 2012 | 5.95 | 6.00 | 5.90 | 5.90 | 39784 |
| April 4, 2012 | 6.10 | 6.10 | 5.83 | 5.96 | 166344 |
| April 3, 2012 | 6.34 | 6.34 | 6.115 | 6.13 | 104552 |
| April 2, 2012 | 6.27 | 6.35 | 6.18 | 6.34 | 143293 |
| March 30, 2012 | 6.28 | 6.35 | 6.20 | 6.26 | 170648 |
| March 29, 2012 | 6.20 | 6.27 | 6.07 | 6.25 | 223595 |
| March 28, 2012 | 6.39 | 6.390 | 6.00 | 6.30 | 328403 |
| March 27, 2012 | 6.47 | 6.47 | 6.25 | 6.40 | 198035 |
| March 26, 2012 | 6.50 | 6.50 | 6.391 | 6.47 | 176244 |
| March 23, 2012 | 6.40 | 6.50 | 6.29 | 6.48 | 141089 |
| March 22, 2012 | 6.33 | 6.44 | 6.260 | 6.43 | 219850 |
| March 21, 2012 | 6.07 | 6.32 | 6.07 | 6.31 | 175940 |
| March 20, 2012 | 6.02 | 6.13 | 5.85 | 6.07 | 110020 |
| March 19, 2012 | 5.79 | 6.15 | 5.76 | 6.05 | 281539 |
| March 16, 2012 | 5.87 | 5.88 | 5.75 | 5.81 | 184378 |
DUSA News
$DUSA - Initial Stop hit. Trade close @ Initial Stop of $5.10 - http://stks.co/3so5
about 12 days ago by TraderFoxxx
about 12 days ago by TraderFoxxx
$DUSA forms bearish "Diamond Top" chart pattern. http://stks.co/3mUY
about 18 days ago by RecogniaEvents
about 18 days ago by RecogniaEvents
Listen to $DUSA Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3iR7
about 21 days ago by earningscast
about 21 days ago by earningscast
DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results
May 08, 6:30AM GlobeNewswire
May 08, 6:30AM GlobeNewswire
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R) Kerastick(R) Photodynamic Therapy
Apr 24, 7:30AM GlobeNewswire
Apr 24, 7:30AM GlobeNewswire
DUSA Pharmaceuticals Introduces Teeing Off Against Sun Damage(TM) Campaign to Raise Awareness of Actinic Keratosis
Apr 10, 8:30AM GlobeNewswire
Apr 10, 8:30AM GlobeNewswire
Trade Signal-New $DUSA -BTO @ 6.48-Limit w/5.10-Stop on the Wkly Chart w/.5N @ Risk http://chart.ly/t5llhwx
about 64 days ago by TraderFoxxx
about 64 days ago by TraderFoxxx
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
Mar 23, 8:00AM GlobeNewswire
Mar 23, 8:00AM GlobeNewswire
$DUSA http://stks.co/2wc5 broke over lower range on volume of 150% of full day average - has a level overhead
about 71 days ago by StockTiger
about 71 days ago by StockTiger
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
Mar 19, 8:30AM GlobeNewswire
Mar 19, 8:30AM GlobeNewswire
DUSA Pharmaceuticals to Present at Roth Capital Partners 24th Annual OC Growth Stock Conference
Mar 07, 8:30AM GlobeNewswire
Mar 07, 8:30AM GlobeNewswire
Listen to $DUSA Q4 2011 earnings call - live at 08:30 AM, ondemand after - http://stks.co/2giF
about 84 days ago by earningscast
about 84 days ago by earningscast
DUSA Pharmaceuticals Reports Full Year 2011 Corporate Highlights and Financial Results
Mar 06, 6:30AM GlobeNewswire
Mar 06, 6:30AM GlobeNewswire
DUSA Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
Feb 08, 8:30AM GlobeNewswire
Feb 08, 8:30AM GlobeNewswire
DUSA Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Feb 06, 9:10AM GlobeNewswire
Feb 06, 9:10AM GlobeNewswire
DUSA Pharmaceuticals, Inc. (DUSA) CEO to Ring The NASDAQ Stock Market Opening Bell
Dec 21, 12:20PM GlobeNewswire
Dec 21, 12:20PM GlobeNewswire
DUSA Pharmaceuticals Reports Third Quarter 2011 Corporate Highlights and Financial Results
Nov 10, 6:30AM GlobeNewswire
Nov 10, 6:30AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DUSA | 5.44 | +0.04 | +0.74% | 134.10M |
| DUK | 21.96 | +0.16 | +0.73% | 29.38B |
| DUG | 27.46 | +0.20 | +0.73% | |
| DUF | 14.83 | -0.07 | -0.47% | 515.79M |
| DUCK | 8.11 | +0.09 | +1.12% | 31.14M |
| DUC | 12.40 | +0.06 | +0.49% | |
| DTV | 46.40 | +0.03 | +0.06% | 31.39B |
| DRH | 9.85 | -0.01 | -0.10% | 1.661B |
| DRE | 13.72 | -0.07 | -0.51% | 3.569B |
| DRD | 6.24 | +0.06 | +0.97% | 240.18M |